Online Only Articles

The transcriptomic profile of CD138+ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged

Department of Medicine and Surgery, University of Parma, Parma;CORELAB Azienda Ospedaliero-Universitaria di Parma, Parma
Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan;Department of Oncology and Hemato-oncology, University of Milan, Milan
Department of Medicine and Surgery, University of Parma, Parma;Hematological Unit Azienda Ospedaliero-Universitaria di Parma, Parma
Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan;Department of Oncology and Hemato-oncology, University of Milan, Milan
Department of Medicine and Surgery, University of Parma, Parma;CORELAB Azienda Ospedaliero-Universitaria di Parma, Parma
Department of Medicine and Surgery, University of Parma, Parma;Hematological Unit Azienda Ospedaliero-Universitaria di Parma, Parma
Hematological Unit Azienda Ospedaliero-Universitaria di Parma, Parma
Department of Medicine and Surgery, University of Parma, Parma
Department of Medicine and Surgery, University of Parma, Parma
Department of Medicine and Surgery, University of Parma, Parma
Department of Medicine and Surgery, University of Parma, Parma
Department of Medicine and Surgery, University of Parma, Parma
Pathology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan;Department of Oncology and Hemato-oncology, University of Milan, Milan
Department of Medicine and Surgery, University of Parma, Parma;CORELAB Azienda Ospedaliero-Universitaria di Parma, Parma;Hematological Unit Azienda Ospedaliero-Universitaria di Parma, Parma
Vol. 104 No. 10 (2019): October, 2019 https://doi.org/10.3324/haematol.2018.209999